In the past two decades the field of hand osteoarthritis (OA) has moved from resignation to action. Despite progress, such as the recognition of the phenotypic heterogeneity of hand OA (including inflammation- and/or metabolic syndrome-associated hand OA) and the standardization of imaging and treatment outcomes, challenges remain in achieving truly disease-modifying therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Maheu, E. & Berenbaum, F. Time for new outcome measures in hand osteoarthritis? Nat. Clin. Pract. Rheumatol. 5, 136–138 (2009).
Haugen, I. K. et al. 2023 EULAR classification criteria for hand osteoarthritis. Ann. Rheum. Dis. 8, 1428–1435 (2024).
Mathiessen, A., Slatkowsky-Christensen, B., Kvien, T. K., Hammer, H. B. & Haugen, I. K. Ultrasound-detected inflammation predicts radiographic progression in hand osteoarthritis after 5 years. Ann. Rheum. 75, 825–830 (2026).
Damman, W. et al. Bone marrow lesions and synovitis on MRI associate with radiographic progression after 2 years in hand osteoarthritis. Ann. Rheum. Dis. 76, 214–217 (2017).
Hodkinson, B., Maheu, E., Michon, M., Carrat, F. & Berenbaum, F. Assessment and determinants of aesthetic discomfort in hand osteoarthritis. Ann. Rheum. Dis. 71, 45–49 (2012).
Hunter, D. J. et al. OARSI clinical trials recommendations: hand imaging in clinical trials in osteoarthritis. Osteoarthritis Cartilage 23, 732–746 (2015).
Binvignat, M. et al. Identification of symptom phenotypes of hand osteoarthritis using hierarchical clustering: results from the DIGICOD cohort. Arthritis Care Res. 75, 1494–1502 (2023).
Haugen, I. K. et al. Inflammation as a treatment target in hand osteoarthritis: a review of previous studies and future perspectives. J. Rheumatol. https://doi.org/10.3899/jrheum.2025-0206 (2025).
Charton, A. et al. Metabolic syndrome is associated with more pain in hand osteoarthritis: results from the DIGICOD cohort. Osteoarthr. Cartil. Open 7, 100573 (2025).
Binvignat, M. et al. Serum intestinal permeability biomarkers are associated with erosive hand osteoarthritis and radiographic severity: results from the DIGICOD cohort. Osteoarthritis Cartilage 33, 736–744 (2025).
Courties, A. et al. Coronary heart disease is associated with a worse clinical outcome of hand osteoarthritis: a cross-sectional and longitudinal study. RMD Open 3, e000344 (2017).
Tomi, A. L. et al. Increased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: Data from the cross-sectional METAFIB-OA study. Ann. Rheum. Dis. 75, 2101–2107 (2016).
Kloppenburg, M. et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann. Rheum. Dis. 78, 16–24 (2019).
Wittoek, R., Verbruggen, G., Vanhaverbeke, T., Colman, R. & Elewaut, D. RANKL blockade for erosive hand osteoarthritis: a randomized placebo-controlled phase 2a trial. Nat. Med. 30, 829–836 (2024).
Kjeken, I. et al. Efficacy and safety of non-pharmacological, pharmacological and surgical treatments for hand osteoarthritis in 2024: a systematic review. RMD Open 11, e004963 (2025).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Berenbaum, F., Maheu, E. A firm grip on hand OA: 20 years of progress and prospects. Nat Rev Rheumatol 21, 646–647 (2025). https://doi.org/10.1038/s41584-025-01304-y
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41584-025-01304-y
This article is cited by
-
The next breakthrough in rheumatology will require prioritizing diversity
Nature Reviews Rheumatology (2025)